Welcome to 340B Report—the only subscription-based news service that provides breaking news and analysis about the federal 340B Drug Pricing Program in real time. We follow all 340B program developments big and small—in federal government agencies, Congress, courts, the states, associations, the private sector, academia, and more. We have a combined six decades of experience in journalism and with the 340B program. That background informs our reporting and analysis in a way unmatched by others. If your success rides on staying on top of 340B, 340B Report has you covered.
340B Report will launch in January 2020. Sign up now so you don’t miss the first issue.
In the meantime, tell your friends!